Disseminated intravascular coagulation (DIC) can be a rare initial manifestation of adenocarcinoma of the prostate. We present a case in which DIC was the symptom leading to the suspicion of a prostatic tumour. The performance of a prostate biopsy in this situation exacerbated the initial coagulation disorder. This case highlights the risks of prostate biopsy in patients with a suspicion of advanced adenocarcinoma of the prostate. The difficulty of treating DIC in this clinical situation is also discussed.
Introduction
Disseminated intravascular coagulation (DIC) is a disorder associated with adenocarcinoma of the prostate, which on rare occasion, can be the initial manifestation of this tumour. The correct diagnosis of this coagulopathy can be difficult and its therapeutic management continues to be a matter of controversy. We present a case, in which the first clinical manifestation of adenocarcinoma of the prostate was a bleeding diathesis with multiple haemorrhagic and thrombotic complications after performing a diagnostic prostate biopsy.
Case presentation
We present the case of a 70-year-old male patient with no past history of disease who, 3 months prior to admission, developed episodes of rectorrhagia and mechanical-type lumbar pain. On physical examination there was pain on percussion over the lumbar spine, and rectal examination revealed a poorly-defined prostate of soft consistency. The results of the laboratory analyses were: platelets 25 000; fibrinogen, 127 mg/ml; D-dimers, 2.47 ng/dl; prothrombin time, 77%. No platelet clumping was observed on the blood film. The complimentary investigations performed were colonscopy (normal except for internal haemorrhoids), tumour markers (PSA: 8138 ng/ml; CEA and Ca19.9 unaltered) and a bone scan which showed pathological deposits in the cranium, cervical, dorsal and lumbar column, anterior and posterior portions of the right ribs, right hemipelvis and right femur. Prostatic FNAB was indicated based on these findings, the result of which was nodular hyperplasia. It was therefore decided to perform a prostate biopsy in order to reach a histopathological diagnosis. At 24 h after the biopsy the patient developed frank haematuria and worsening of the coagulation tests (platelets: 18 000, fibrinogen 93 mg/ml, D-dimers 410 ng/dl, prothrombin time: 54%), requiring supportive treatment with platelets, red blood cells, fresh frozen plasma and antithrombin III over the following days due to persistence of the haematuria and of the alterations in the laboratory tests. The result of the prostate biopsy confirmed an infiltration of the prostate by adenocarcinoma, and it was decided to start treatment with complete hormonal blockade. On the 6th day after the prostate biopsy, the patient developed chest pain and dyspnoea of sudden onset. A ventilation/perfusion gamma scan was requested which confirmed the diagnosis of pulmonary thromboembolism and treatment was therefore started with low molecular weight heparin. The haematuria and the disturbances of coagulation persisted. On day 17 after the prostate biopsy the patient suffered disorientation, global aphasia and right hemiplegia of sudden onset. A CT scan was performed, revealing signs of an extensive infarct in the area of the left middle cerebral artery. The patient died 72 h later.
Discussion
Disturbances of coagulation are frequent in oncology patients, but their clinical expression as bleeding is less common. 1 One of these disturbances is disseminated intravascular coagulation (DIC) associated with bleeding diatheses which patients with advanced adenocarcinoma of the prostate can present 2 and which have been described in some cases as the first manifestation of this tumour. 3 DIC occurs as a result of the release of procoagulant substances, such as tissue factor, into the blood stream. 4 Ultrasound-guided transrectal prostate biopsy is usually a safe procedure, 5 although cases of DIC have been reported after performing this investigation, 6 as can occur after other surgical procedures. 7 The manipulation of the tumour during the biopsy probably favours this passage of these procoagulant substances to the blood stream. 8 This technique proved catastrophic in our patient as it exacerbated the DIC which, according to classical criteria, was defined as compensated; 9 we later considered that the biopsy should probably not have been undertaken in this clinical context.
The treatment of this complication is not clear, as the majority of publications on this subject are case studies or small patient series, most of which are hormonerefractory. 7 The replacement of blood components and anticoagulation could be of value in the treatment of DIC. However, the use of heparin is also not well established in these cases. Although it would appear logical to administer heparin in order to interrupt the activation of coagulation, this could also lead to an exacerbation of the haemorrhagic phenomena. Its use is probably indicated in patients with DIC with predominantly thrombotic events, 10 as was the case in our patient in whom, in view of the thrombotic complications which developed, we would question whether the administration of anticoagulants could have altered the clinical course.
In conclusion, our patient developed untreatable DIC after undergoing prostate biopsy. We would therefore recommend special care when indicating this test in patients with suspected advanced prostate cancer or the performance of other invasive tests in patients with known prostate cancer.
